$RNA 3 SEC Filings

Filed On	Filing
26 Feb 2026	Form 3: Winslow Brendan R., Chief Financial Officer Holds 13,601 shares of Common Stock
26 Feb 2026	Form 3: Flanagan W. Michael, Director Holds 54,786 shares of Common Stock
26 Feb 2026	Form 3: Boess Carsten, Director Holds 11,005 shares of Common Stock
26 Feb 2026	Form 3: Boyce Sarah, Director Holds 265,086 shares of Common Stock
26 Feb 2026	Form 3: Gallagher Kathleen P., Director Holds 28,861 shares of Common Stock
26 Feb 2026	Form 3: Wilson Troy Edward, Director Holds 10,360 shares of Common Stock
26 Feb 2026	Form 3: Kenney Stephanie, See Remarks Holds 5,460 shares of Common Stock
26 Feb 2026	Form 3: Hughes Steven George, Chief Medical Officer Holds 43,097 shares of Common Stock
26 Feb 2026	Form 3: Hoyos Rocio Martin, Chief Strategy Officer Holds 16,660 shares of Common Stock
26 Feb 2026	Form 3: Younis Husam, Chief Scientific Officer Holds 22,657 shares of Common Stock
26 Feb 2026	Form 3: Skerjanec Simona, Director Holds 5,902 shares of Common Stock

Comments